Abbott Laboratories ROE 2006-2019 | ABT

Current and historical return on equity (ROE) values for Abbott Laboratories (ABT) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Abbott Laboratories ROE for the three months ending September 30, 2019 was 17.65%.
Abbott Laboratories ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-09-30 $3.29B $32.02B 10.47%
2019-06-30 $2.90B $31.89B 9.29%
2019-03-31 $2.62B $31.13B 8.49%
2018-12-31 $2.37B $30.72B 7.64%
2018-09-30 $0.89B $30.90B 2.85%
2018-06-30 $0.93B $30.77B 2.95%
2018-03-31 $0.48B $31.60B 1.50%
2017-12-31 $0.48B $31.10B 1.51%
2017-09-30 $2.10B $32.22B 7.23%
2017-06-30 $1.17B $31.79B 4.46%
2017-03-31 $1.50B $31.55B 6.40%
2016-12-31 $1.40B $20.72B 6.73%
2016-09-30 $1.37B $20.90B 6.53%
2016-06-30 $2.28B $20.80B 10.82%
2016-03-31 $2.45B $20.84B 11.31%
2015-12-31 $4.42B $21.33B 20.18%
2015-09-30 $4.56B $21.22B 20.74%
2015-06-30 $4.52B $23.13B 20.14%
2015-03-31 $4.20B $21.99B 18.60%
2014-12-31 $2.28B $21.64B 9.95%
2014-09-30 $1.97B $22.99B 8.25%
2014-06-30 $2.40B $23.70B 9.96%
2014-03-31 $2.41B $23.49B 10.14%
2013-12-31 $2.58B $25.27B 10.94%
2013-09-30 $3.04B $23.79B 12.70%
2013-06-30 $4.02B $22.43B 16.22%
2013-03-31 $5.27B $22.68B 20.82%
2012-12-31 $5.96B $26.81B 22.93%
2012-09-30 $6.53B $27.10B 25.67%
2012-06-30 $4.89B $24.57B 19.69%
2012-03-31 $5.11B $25.54B 20.18%
2011-12-31 $4.73B $24.53B 18.84%
2011-09-30 $4.55B $24.69B 18.45%
2011-06-30 $5.14B $26.47B 21.54%
2011-03-31 $4.49B $24.72B 20.18%
2010-12-31 $4.63B $22.77B 21.71%
2010-09-30 $4.73B $21.48B 22.06%
2010-06-30 $5.31B $20.00B 24.84%
2010-03-31 $5.31B $21.01B 24.84%
2009-12-31 $5.75B $23.19B 27.87%
2009-09-30 $5.74B $21.38B 29.91%
2009-06-30 $5.35B $19.92B 28.61%
2009-03-31 $5.38B $17.98B 29.17%
2008-12-31 $4.88B $17.52B 26.45%
2008-09-30 $4.55B $19.35B 24.55%
2008-06-30 $4.18B $18.96B 23.76%
2008-03-31 $3.85B $17.98B 23.05%
2007-12-31 $3.61B $17.82B 22.87%
2007-09-30 $1.93B $15.61B 13.00%
2007-06-30 $1.93B $15.33B 12.99%
2007-03-31 $1.55B $14.32B 10.47%
2006-12-31 $1.72B $14.05B 11.58%
2006-09-30 $3.17B $15.63B 21.24%
2006-06-30 $3.13B $15.19B 21.50%
2006-03-31 $3.40B $14.44B 23.64%
2005-12-31 $3.37B $14.42B 23.56%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $148.126B $30.578B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $144.847B 20.33
Stryker (SYK) United States $74.230B 24.96
Boston Scientific (BSX) United States $55.990B 26.43
Baxter (BAX) United States $40.262B 24.42
EssilorLuxottica Societe Anonyme (ESLOY) France $32.646B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.479B 18.49
Terumo (TRUMY) Japan $26.826B 33.48
Lonza Group Ag (LZAGY) Switzerland $25.848B 0.00
Coloplast (CLPBY) Denmark $24.710B 39.45
ResMed (RMD) United States $20.688B 38.16
Smith & Nephew SNATS (SNN) United Kingdom $18.505B 0.00
Sunny Optical Technology (SNPTF) China $18.021B 0.00
Insulet (PODD) United States $10.756B 511.73
Bio-Rad Laboratories (BIO) United States $10.475B 50.28
Canopy Growth (CGC) Canada $7.071B 0.00
Hill-Rom Holdings (HRC) United States $6.970B 20.53
Perrigo (PRGO) Ireland $6.683B 12.46
William Demant Holdings (WILYY) Denmark $6.665B 0.00
DiaSorin S.p.A (DSRLF) Italy $6.420B 0.00
Haemonetics (HAE) United States $6.015B 40.64
Shandong Weigao Medical Polymer (SHWGF) China $5.382B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.751B 29.54
Aurora Cannabis (ACB) Canada $3.724B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.498B 0.00
ICU Medical (ICUI) United States $3.474B 22.66
Neogen (NEOG) United States $3.331B 55.74
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.989B 0.00
Quidel (QDEL) United States $2.472B 23.46
National Vision Holdings (EYE) United States $2.103B 47.83
Agios Pharmaceuticals (AGIO) United States $1.910B 0.00
Cardiovascular Systems (CSII) United States $1.587B 0.00
InMode (INMD) Israel $1.452B 0.00
VAREX IMAGING (VREX) United States $1.251B 28.84
Aphria (APHA) $1.250B 0.00
AtriCure (ATRC) United States $1.103B 0.00
Phibro Animal Health (PAHC) United States $0.926B 17.34
Lantheus Holdings (LNTH) United States $0.845B 21.11
Eagle Pharmaceuticals (EGRX) United States $0.845B 21.54
NanoString Technologies (NSTG) United States $0.829B 0.00
TG Therapeutics (TGTX) United States $0.739B 0.00
Omeros (OMER) United States $0.677B 0.00
LeMaitre Vascular (LMAT) United States $0.660B 37.35
PetIQ (PETQ) United States $0.641B 15.68
Cerus (CERS) United States $0.574B 0.00
Quanterix (QTRX) United States $0.563B 0.00
HEXO (HEXO) $0.545B 0.00
Organigram Holdings (OGI) Canada $0.529B 0.00
Surmodics (SRDX) United States $0.527B 55.04
OraSure Technologies (OSUR) United States $0.511B 30.67
Owens & Minor (OMI) United States $0.429B 15.88
MacroGenics (MGNX) United States $0.389B 0.00
Utah Medical Products (UTMD) United States $0.381B 27.58
BioLife Solutions (BLFS) United States $0.340B 104.56
Meridian Bioscience (VIVO) United States $0.340B 11.69
Zynex (ZYXI) United States $0.295B 33.33
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.274B 0.00
Viemed Healthcare (VMD) United States $0.261B 0.00
Bovie Medical (APYX) United States $0.245B 0.00
United Health Products (UEEC) United States $0.208B 0.00
Repro-Med Systems (KRMD) United States $0.183B 0.00
Vapotherm (VAPO) United States $0.169B 0.00
InfuSystems Holdings (INFU) United States $0.143B 0.00
Cytosorbents (CTSO) United States $0.143B 0.00
Fonar (FONR) United States $0.134B 9.40
Female Health (VERU) United States $0.129B 0.00
Liberty Health Sciences (LHSIF) Canada $0.128B 0.00
Rockwell Medical (RMTI) United States $0.122B 0.00
Chimerix (CMRX) United States $0.103B 0.00
United-Guardian (UG) United States $0.089B 22.43
Chembio Diagnostics (CEMI) United States $0.079B 0.00
Nephros (NEPH) United States $0.068B 0.00
MRI Interventions (MRIC) United States $0.055B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.052B 0.00
MTech Acquisition (KERN) United States $0.045B 0.00
Surface Oncology (SURF) United States $0.045B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.022B 0.00
Senestech (SNES) United States $0.019B 0.00
GUARDION HEALTH (GHSI) United States $0.019B 0.00
Myomo (MYO) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Akers Biosciences Inc (AKER) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00